Authors
Ferreira, J. J., Kent, L. N., Gonzalez-Cota, A., Peramsetty, N., Whitter, G. C., Li, E., Spivak, S., Ma, X. J., England, S. K., Santi, C. M.
Abstract
Arginine vasopressin (AVP) increases excitability of myometrial smooth muscle cells (MSMCs) through Gq-coupled AVP receptors. Although excitability requires membrane depolarization, the mechanisms linking AVP receptor activation to membrane depolarization and Ca2+ signaling are incompletely understood. Here, we show that AVPR1 is the predominant AVP receptor in primary MSMCs. In Xenopus oocytes, AVP signals through AVPR1 to inhibit SLO2.1-mediated potassium currents, reducing current amplitude to approximately 60% of control currents. Consistent with suppression of a hyperpolarizing conductance, AVP depolarized a myometrial cell line (hTERT-HM) and increased intracellular Ca2+ signaling. Analysis of Ca2+ dynamics revealed that the initial Ca2+ peak was largely preserved under conditions limiting extracellular Ca2+ entry, consistent with intracellular store release. Conversely, the oscillatory phase depended on extracellular Ca2+ influx and was reduced by SLO2.1 knockdown. Together, these findings support a model in which AVP preferentially signals through AVPR1A to inhibit SLO2.1, depolarize myometrial cells, enhance VDCC-dependent Ca2+ entry, and promote excitability, enhancing conditions for uterine contraction.
Preprint server:
bioRxiv
The authors list and abstract were imported from bioRxiv on 13 Aug 2026.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 16
- Comments 0